May 19, 2017 / 6:38 AM / 3 months ago

BRIEF-Biofrontera Q1 net loss at 3.5 million euros

May 19 (Reuters) - BIOFRONTERA AG

* SALES INCREASED C. 160% TO EUR2.6 MILLION FOR Q1 2017, COMPARED TO EUR1.0 MILLION IN SAME PERIOD 2016.

* NET LOSS WAS EUR(3.5) MILLION FOR Q1 2017, COMPARED TO EUR(448) THOUSAND FOR SAME PERIOD IN 2016.

* RESEARCH AND DEVELOPMENT COSTS AMOUNTED TO EUR1.1 MILLION IN Q1, AN INCREASE OF 12%, YEAR-OVER-YEAR. THESE COSTS WERE MAINLY DUE TO DEVELOPMENT PARTNERSHIPS.

* INTENDS TO APPLY FOR BCC APPROVAL IN U.S., AND HAS APPLIED FOR A MEETING WITH FDA, WHICH IS EXPECTED TO BE HELD IN Q2 OF 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below